The U.S. Food and Drug Administration granted premarket notification clearance for two catheters originally developed by Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital; and Nicholas Green, Director of Research and Development at Thrombolex, Inc. The announcement received coverage from Endovascular Today, Scienmag and Bioengineer.org.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH